Related Experiment Video
Updated: Nov 1, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Non-Invasive Sweat-Based Tracking of L-Dopa Pharmacokinetic Profiles Following an Oral Tablet Administration
Jong-Min Moon1, Hazhir Teymourian1, Ernesto De la Paz1
1Department of Nanoengineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
This study introduces a novel, non-invasive method to monitor Levodopa (L-Dopa) levels in Parkinson disease patients using fingertip sweat. This personalized approach tracks drug concentrations dynamically, correlating sweat levels with blood plasma for optimized treatment.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Analytical Chemistry
Background:
- Levodopa (L-Dopa) is the primary treatment for Parkinson disease (PD) symptoms.
- Long-term L-Dopa use leads to motor and non-motor complications due to fluctuating plasma levels and disease progression.
Purpose of the Study:
- To develop and validate the first individualized therapeutic drug monitoring approach for L-Dopa.
- To utilize fingertip sweat for dynamic, non-invasive tracking of L-Dopa concentration.
Main Methods:
- A touch-based, non-invasive detection method using fingertip sweat.
- Instantaneous sweat collection on a hydrogel for transport to a tyrosinase-modified electrode.
- Electrochemical measurement of L-Dopa via dopaquinone reduction.
Main Results:
- Demonstrated a personalized dose-response relationship for L-Dopa in human subjects.
- Established a strong pharmacokinetic correlation between fingertip sweat L-Dopa and capillary blood L-Dopa levels.
Conclusions:
- Fingertip sweat analysis offers a viable, non-invasive method for personalized L-Dopa therapeutic drug monitoring in Parkinson disease.
- This approach may help mitigate L-Dopa-associated complications by enabling precise dose adjustments.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Therapeutic Drug Monitoring: Drug Analysis Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...

